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 ABSTRACT 
Aromatic plant species of genus Thymus are important medicinal plants, highly recommended 
due to a range of therapeutic properties of their essential oil (thyme oil): antirheumatic, 
antiseptic, antispasmodic, antimicrobial, cardiac, carminative, diuretic and expectorant. Oil is 
also beneficial in boosting the immune system, and helps to fight colds, flu, infectious 
diseases and chills. It is proved to be a urinary antiseptic, being very helpful for cystitis and 
urethritis. Scientific validation of traditional uses, and phytochemical and bioactivity 
evaluation of essential oils from Thymus serpyllum, Thymus algeriensis and Thymus vulgaris 
was performed.   
GC/MS analysis revealed thymol as major component of T. algeriensis, T. vulgaris and T. 
serpyllum, with a contribution of 56.02%, 48.92% and 38.50%, respectively. The three 
essential oils (EOs) exhibited a signiﬁcant antimicrobial activity against all the tested strains, 
T. serpyllum oil being the most potent (MIC 2.5-5 µg/mL, MBC 5-10 µg/mL; MIC 1-2 
µg/mL, MFC 2-4 µg/mL). In addition, T. serpyllum oil revealed the highest antioxidant 
activity in all the assays and was also the most effective one against all the tested cell lines, 
presenting GI50 values of 7.02-52.69 µg/mL. Moreover, the EOs did not show any toxicity, at 
the tested concentrations (<400 µg/mL), for porcine liver primary cell culture. In addition to 
their traditional use in food and cosmetics, the great potential of the tested Thymus essential 
oils for application in oral disease and anticancer treatments, encourage further investigation.  
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1. Introduction 
The genus Thymus L. belongs to the family Lamiaceae, and consists of about 215 to 
350 species, according to different literature data (Cronquist, 1988; Zaide and Crow, 2005). 
They are usually herbaceous perennials, small shrubs occurring within the Mediterranean 
region, which is a center of the entire genus, and are also characteristic for Asia, Southern 
Europe and North Africa (Maksimovic et al., 2008). Throughout the history, the aerial parts 
and the volatile constituents of Thymus species are highly recommended; they are commonly 
used as herbal teas, condiments and spices, so as for various medicinal purposes (Stahl-
Biskup and Saez, 2002). Many ethnomedicinal properties are attributed to infusions, 
decoctions and essential oils of the aerial parts of Thymus species, which are used due to their 
tonic, carminative, digestive, antispasmodic, antimicrobial, antioxidant, antiviral, anti-
inflammatory and expectorant activity, so as for the treatment of colds (Nickavar et al., 2005;  
Pirbalouti, 2009). Thyme oil is among the world’s top 10 essential oils also used as a 
preservative for food (Stahl-Biskup and Saez, 2002). The aromatic and medicinal properties 
of the Thymus species have made it one of the most popular herbs. The genus Thymus has 
numerous species and varieties and their essential oils have been studied earlier (Guillen and 
Manzanos, 1998). However, there are considerable research interests to continue with 
studying of many other biological properties of Thymus essential oils (Stahl-Biskup and Saez, 
2002; Shin and Kim, 2005). 
Thymus vulgaris L. is a perennial herb indigenous in central and southern Europe, 
Africa and Asia. It is rich in essential oils and antioxidative phenolic substances (WHO, 
1999). It is widely used in folk medicine for the treatment of a variety of diseases including 
gastroenteric and bronchopulmonary disorders, anthelmintic, carminative, sedative, 
diaphoretic (Rustaiyan et al., 2000). It has been reported that its essential oil possesses 
numerous biological activities including antiworm, antiseptic, antispasmodic, antimicrobial 
(Marino et al., 1999) and antioxidant (Miura et al., 2002; Soliman and Badeaa, 2002; Pina-
Vaz et al., 2004). T. vulgaris is well-known species of the genus Thymus and extensively 
studied for chemical and biological activity (Simandi et al., 2001; Soković et al., 2008, 2009) 
T. algeriensis is the most widespread North African species. It is endemic to Libya, 
Tunisia, Algeria and Marocco (Houmani et al, 2012). T. algeriensis is largely used, fresh or 
dried, only as a culinary herb. Its chemical compositions have been studied previously 
(Giordiani et al., 2008; Hazzit et al., 2009; Giweli et al., 2013), tough results of its biological 
activity are scarce. This species is also used in traditional medicine in the form of a fresh or 
dry spicy herb, in respiratory disorders, against illnesses of the digestive tube and anti-
abortion (Giweli et al., 2013). 
T. serpyllum, known as wild thyme, is native to Mediterranean Europe and North 
Africa, mainly at the higher altitudes. It is acknowledged for its use in home remedies. The 
plant is aromatic, antiseptic, diaphoretic, analgesic, carminative, expectorant and diuretic; 
also it acts as an emmanagogue, carminative, and stimulant, also being used in mouth washes, 
gargles, cough and colds (Farooqi et al., 2005). Its essential oil contains various compounds 
that are very powerful, proven disinfectants enhancing the immune system and ﬁghting 
infections. The oil relieves rheumatism, and is also used in hear loss-treatments (Aziz and 
Rehman, 2008). 
To the best of our knowledge, as far as the literature is concerned, this study 
represents the first report on cytotoxic activity of the three thyme oils on the following tumor 
cell lines: lung, breast, cervical, colon and gastric cancer. In addition, toxicity of the oils to 
non-tumor cells was also evaluated. The oils were submitted to bioactivity evaluation by 
measuring in vitro antioxidant potential. Even though, the antibacterial and antifungal activity 
exhibited by Thymus species has already been demonstrated (Cruz et al., 1989; Karaman et 
al., 2001; Rota et al., 2004; Couladis 2004; Soković et al., 2008, 2009) unfortunately, there 
are only few quantitative data (minimal inhibitory concentration or minimal 
bactericidal/fungicidal concentration) related to the antimicrobial activity of the oils against 
the human oral microorganisms. 
Therefore, our primary objective was to characterize the essential oils of T. serpyllum, 
T. algeriensis and T. vulgaris, and to evaluate their antimicrobial, antioxidant, antitumor and 
cytotoxic attributes, in an attempt to contribute to their use, as alternatives, in microbial 
control and cancer therapy in humans. 
 
2. Material and methods 
 
2.1. Essential oil         
Wild thyme oil (Thymus serpylum L.) is commercial sample from Greece local pharmacy. 
The samples from wild growing Thymus algeriensis plants were collected during the 
flowering stage in May 2010 from Zentan (Libya), which is located on the top of Western 
mountain (Aljabel Algarbi) at altitude about 700 m a.s.l. The plants were identified by Dr A. 
Felaly, Faculty of Science, Al-Gabel Al-Garbi University Libya. The samples were dried in 
shadow at room temperature for 10 days. Voucher specimens where deposited in Herbarium 
of the Institute of Botany and Botanical Garden "Jevremovac" (BEOU), (voucher No. 
16614). Thymus vulgaris L. plants were collected during the summer (July) in 2006 at the 
experimental field of the Institute for Medicinal Plant Research “Josif Pančić” in Pančevo 
(Serbia). The species was identified bz Prof. Petar Marin, at the Institute of Botany, Faculty 
of Biology of the University of Belgrade, where a voucher specimen is deposited (voucher 
No 17432). 
 
2.2 Isolation of the essential oil 
Air-dried aerial parts of Thymus vulgaris and T. algeriensis deprived from wooden parts (100 
g) were submitted to hydrodistillation, using Clevenger-type apparatus for 3 h, according to 
the standard procedure. The obtained essential oils were dried over Na2SO4 and stored in a 
sealed dark vials, then kept at 4ºC prior to further analysis.  
 
2.3. Essential oil analysis 
The EO sample was diluted in ethanol (1 µL) and injected in a split-mode (1:30). Gas 
chromatography was performed on GC Agilent Technologies 7890A apparatus, equipped 
with the split-splitless injector attached to HP-5 column (30 m × 0.32 mm, film thickness 
0.25 µm) and fitted to flame-ionisation detector (FID). Operating conditions were as follows: 
carrier gas was H2 (1 mL/min/210°C); temperatures were set as follows: injector at 250°C 
and detector at 280°C, while the column temperature was linearly programmed 40–260°C at 
4°C/min. The percentage composition was computed from the peak areas, without correction 
factors. 
The GC-MS was performed on HP G 1800C Series II GCD analytical system 
equipped with HP-5MS column (30 m × 0.25 mm, film thickness 0.25 µm). Carrier gas was 
He (1 mL/min). Other chromatographic conditions were as those for GC-FID. Transfer line 
was heated at 260°C. Mass spectra were recorded in EI mode (70 eV), in a range of m/z 40–
450. 
The identification of individual constituents was accomplished by comparison of their 
spectra with those from available MS libraries (NIST/Wiley) and by comparison of their 
experimentally determined retention indices (calibrated AMDIS), with data from the 
literature (Adams, 2009). 
 
2.4. Microorganisms 
The following six clinical oral isolates were tested: Streptococcus mutans (IBR S001), 
Streptococcus sanguis (two strains, IBR S002 & IBR S003), Streptococcus pyogenes (two 
strains, IBR S004 & IBR S005), Staphylococcus aureus (ATCC 25923), Pseudomonas 
aeruginosa (IBR P001), and Lactobacilus sp. (IBR L002). In antifungal assay, fifty eight 
clinical isolates of Candida spp., and two ATCC strains were used (Candida albicans ATCC 
10231 and Candida tropicalis ATCC 750). The reference strains were obtained from the 
Laboratory of Mycology at the Institute for Biological Research ''Siniša Stanković'', 
University of Belgrade, Serbia.  
The bacteria species were maintained in Mueller Hinton Agar and Triptic Soy Agar 
(MHA, TSA, Merck, Germany). Strains of Candida spp. were maintained on Sabourand 
Dextrose Agar (SDA, Merck, Germany). All clinical oral isolates were obtained by rubbing a 
sterile cotton swab over oral mucosa from patients at the Department of Pediatric and 
Preventive Dentistry, Faculty of Dental Medicine, University of Belgrade, Serbia.  
The colonies obtained were analyzed for morphological, cultural and physiological 
characteristics. Proper identification of oral bacteria (Cecchini et al. 2012) and fungi (Nikolic 
et al. 2012) colonies were performed. 
 
2.5. Antimicrobial activity 
Minimum inhibitory (MIC) and minimum bactericidal/fungicidal (MBC/MFC) 
concentrations were determined by microdilution method in 96 well microtitre plates 
described by CSLI (2006) with modifications. Briefly, fresh overnight cultures of bacteria 
and yeasts were adjusted with sterile saline to a concentration of 1.0 x 105 CFU/per well. The 
fungal spores were washed from the surface of agar plates with sterile 0.85% saline 
containing 0.1% Tween 80 (v/v). The spores suspension was adjusted with sterile saline to a 
concentration of approximately 1.0 x 105 in a final volume of 100 µL per well. The inocula 
were stored at 4°C for further use. Essential oils were added in TSB (Merck, Germany) 
medium for bacteria, SDB medium for C. albicans, and MB medium for fungi. The 
microplates were incubated for 24 h at 37°C for bacteria and yeasts, while 72 h at 28°C for 
fungi. The MIC/MBC values for bacteria and yeasts were detected following the addition of 
40 µL of p-iodonitrotetrazolium violet (INT) 0.2 mg/mL (Sigma I8377) and incubation at 
37°C for 30 min (Tsukatani, 2012). For the fungi, the lowest concentrations without visible 
growth for 72 h at 28°C were defined as MIC, while MFC was determined by serial 
subcultivation of 10 µL into microtiter plates containing 100 µL of broth per well and further 
incubation for 72 h at 28°C. The lowest concentration with no visible growth was defined as 
the MFC, indicating 99.5% killing of the original inoculum. Positive controls of antibiotics 
(Ampicillin and Streptomycin), mycotic (Fluconazole) and commercial antimicrobial 
preparation (Hexoral and Chlorhexidine 0.05%) were used in both experiments. 
 
2.6 Cytotoxicity in human tumor cell lines and non-tumor primary culture  
Five human tumor cell lines were used: MCF7 (breast adenocarcinoma), NCI-H460 
(non-small cell lung cancer), HCT15 (colon carcinoma), HeLa (cervical carcinoma), and 
HepG2 (hepatocellular carcinoma). Cells were routinely maintained as adherent cell cultures 
in RPMI-1640 medium containing 10% heat-inactivated fetal bovine serum (FBS) and 2 mM 
glutamine (MCF-7, NCI-H460 and HCT-15) or in DMEM supplemented with 10% FBS, 2 
mM glutamine, 100 U/mL penicillin and 100 mg/mL streptomycin (HeLa and HepG2 cells), 
at 37 ºC, in a humidified air incubator containing 5% CO2. Each cell line was plated at an 
appropriate density (7.5 × 103 cells/well for MCF-7, NCI-H460 and HCT15 or 1.0×104 
cells/well for HeLa and HepG2) in 96-well plates. Sulforhodamine B assay was performed 
according to a procedure previously described by the Vichai & Kirtikara  (2006).                         
For hepatotoxicity evaluation, a cell culture was prepared from a freshly harvested 
porcine liver obtained from a local slaughter house, according to a procedure established by 
Guimarães et al. (2013), designed as PLP2. Cultivation of the cells has been carried on with 
direct monitoring by the phase contrast microscope, every two to three days. Before 
confluence was reached, cells were subcultured and plated in 96-well plates at a density of 
1.0×104 cells/well, and cultivated in DMEM medium with 10% FBS, 100 U/mL penicillin 
and 100 µg/mL streptomycin. Ellipticine was used as positive control (0.24-65.2 µg/mL). 
Three independent experiments were performed in triplicate, and the results were expressed 
as mean values ± standard deviation (SD).                          
 
2.7. Antioxidant activity 
2.7.1.DPPH radical-scavenging activity 
DPPH radical-scavenging activity was evaluated by using an ELX800 microplate 
reader (Bio-Tek Instruments, Inc; Winooski, USA), and calculated as a percentage of DPPH 
discoloration using the formula: [(ADPPH − AS) / ADPPH] × 100, where AS is the absorbance of 
the solution containing the sample at 515 nm, and ADPPH is the absorbance of the DPPH 
solution (Reis et al., 2012). 
 
2.7.2. Reducing power 
The sample solutions (0.5 mL) were mixed with sodium phosphate buffer 
(200 mmol/L, pH 6.6, 0.5 mL) and potassium ferricyanide (1% (w/v), 0.5 mL). The mixture 
was incubated at 50 °C for 20 min, and trichloroacetic acid (10% (w/v), 0.5 mL) was added. 
The mixture (0.8 mL) was poured in the 48 wells plate, the same with deionized water 
(0.8 mL) and ferric chloride (0.1% (w/v), 0.16 mL), and the absorbance was measured at 
690 nm in the Microplate Reader, as mentioned above (Reis et al., 2012). 
 
2.7.3. Inhibition of β-carotene bleaching 
A solution of β-carotene was prepared by dissolving β-carotene (2 mg) in chloroform 
(10 mL). Two milliliters of this solution were pipetted into a round-bottom flask. The 
chloroform was removed at 40 °C under vacuum, and linoleic acid (40 mg), Tween 80 
emulsifier (400 mg) and distilled water (100 mL) were added to the flask, with vigorous 
shaking. Aliquots (4.8 mL) of this emulsion were transferred into test tubes containing 
sample solutions (0.2 mL). The tubes were shaken and incubated at 50 °C in a water bath. As 
soon as the emulsion was added to each tube, the zero time absorbance was measured at 
470 nm. β-Carotene leaching inhibition was measured by the following formula: β-carotene 
absorbance after 2 h/initial absorbance) × 100 (Reis et al., 2012). 
 
2.7.4.Thiobarbituric acid reactive substances (TBARS) assay 
Porcine (Sus scrofa) brains were obtained from official slaughtered animals, 
dissected, and homogenized with Polytron in an ice cold Tris–HCl buffer (20 mM, pH 7.4) to 
produce a 1:2 (w/v) brain tissue homogenate, which was centrifuged at 3000 × g for 10 min. 
An aliquot (100 µL) of the supernatant was incubated with the sample solutions (200 µL) in 
the presence of FeSO4 (10 mM; 100 µL) and ascorbic acid (0.1 mM; 100 µL), at 37 °C for 
1 h. The reaction was stopped by the addition of trichloroacetic acid (28% (w/v), 500 µL), 
followed by thiobarbituric acid (TBA, 2% (w/v), 380 µL), and then the mixture was heated at 
80 °C for 20 min. After centrifugation at 3000 × g for 10 min, in order to remove the 
precipitated protein, the color intensity of the malondialdehyde (MDA)–TBA complex in the 
supernatant was measured by its absorbance at 532 nm. The inhibition ratio (%) was 
calculated using the following formula: inhibition ratio (%) = [(A − B)/A] × 100%, where the 
A and B represent the absorbance of the control and the sample solution, respectively (Reis et 
al., 2012). 
 
3. Results and Discussion 
 
3.1. Chemical composition 
The results obtained by chemical analysis by GC-MS of T. serpyllum, T. algeriensis 
and Thymus vulgaris essential oils are presented in Table 1. 
In total, 48 compounds were identified. Results showed that oxygenated 
monoterpenes are the major portion of all EOs samples, with highest content observed in T. 
algeriensis (74.61%), and similar content in T. speryllum and T. vulgaris (54.49% and 
58.11%, respectively). Twenty nine compounds were identified in T. serpyllum oil, which 
accounts for 99.98% of the total oil. The major constituent of the oil was thymol (56.02%), 
followed by carvacrol (14.00%) and p-cymene (6.27%). GC-MS analysis of T. algreriensis 
oil showed 45 compounds representing 99.64% of the total oil. Thymol was the main 
constituent (38.50%) followed by p-cymene, terpinene and bornyl acetate and borneol 
(8.91%, 7.19%, 7.03% and 6.07%, respectively). In the oil of T. vulgaris, 26 constituents 
represented 99.06% of the total oil, with thymol also being the major constituent (49.10%) 
along with p-cymene (20.01%). 
According to presented results it is obvious that the oils from all the three Thymus 
species belong to “thymol chemotype”.  
Many studies on the chemical composition of the oils from the plants belonging to the 
genus Thymus were conducted, including T. serppyllum, T. algeriensis and T. vulgaris (Stahl-
Biskup, 1991; Houmania et al., 2002; Dob et al, 2006; Kizil and Uyart, 2006, Saad et al., 
2010). 
Our results on chemical profiling of T. serpyllum essential oil are in agreement with 
several other studies (Raal et al., 2004; Verma et al., 2009; Verma et al., 2011;), except for 
results of Sfaei-Ghomi et al. (2009), where α-pinene and carvacrol were reported to be the 
major oil components. Besides thymol (30%), carvacrol (20%) was reported to be the second 
main component of the wild thyme oils (Thompson et al., 2003), while results of Rasooli and 
Mirmostafa (2002), showed thymol being the third major component (>18%) in the wild 
thyme oil, after the content of γ-terpinene (>22%) and p-cymene (>20%).  
Regarding the essential oil composition of T. algeriensis, it is already known from the 
literature that it shows really great chemical polymorphism, even in samples collected from 
the same locality (Hazzit et al., 2009), which seems to be common characteristics for the oils 
from Thymus species (Ozguven and Tansi, 1998; Naghdi et al., 2004), and is most frequently 
attributed to the origin, environmental conditions and developmental stage and/or the 
harvesting time (season) of the sourcing plant material (Marković, 2011). Although T. 
algeriensis is one of the rarest Thymus species, various authors already testified the 
occurrence of different oil chemotypes, such as thymol (Hazzit et al., 2009) lilalool (Houmani 
et al, 2002; Dob et al., 2006), carvacrol, and geranyl acetate (Raal et al., 2004) and terpynyl 
acetate (Hazzit et al., 2009), the first two being the most common ones. Present study on the 
chemical profile of T. algeriensis oil reveals that it belongs to thymol chemotype, as it is 
quite common for Maroccan samples of T. algeriensis (Benjulali et al., 1987; Houmani et al, 
2002).  
 On the other hand, chemical proﬁle of our T. vulgaris essential oil sample is in 
agreement with several other reports (Hudaib et al., 2002; Ghasemi et al., 2013), also 
reporting the thymol as a major constituent of this species oil.  
 
3.2. Antimicrobial activity 
The results from the antimicrobial activity tested by microdilution method are 
summarized in Table 2. 
The three EOs exhibited a signiﬁcant antimicrobial activity against all the tested strains.  
Inhibition values range from MIC 2.5-160 µg/mL and MBC 5-320 µg/mL for bacteria, and 
MIC 1-40 µg/mL and MFC 5-80 µg/mL for fungi. T. serpyllum EO showed the strongest 
activity in both cases (MIC 2.5-5 µg/mL, MBC 5-10 µg/mL; MIC 1-2 µg/mL, MFC 2-4 
µg/mL), while T. vulgaris exhibited the lowest antimicrobial potential (MIC 80-160 µg/mL, 
MBC 160-320 µg/mL; MIC 20-40 µg/mL, MFC 40-80 µg/mL). T. algeriensis inhibited the 
growth of selected microorganisms in medium range of MIC 20-80 µg/mL, MBC 40-160 
µg/mL (for bacteria) and MIC 5-10 µg/mL, MFC 10-20 µg/mL (for fungi). Fungi appear to 
be more sensitive compared to bacteria, which could be explained by their different cell 
organization. Comparing the results of essential oils with that of standard drug, hexoral, it 
was concluded that oils are more potent anti-oral-pathogen activity. Essential oil of T. 
serpyllum expressed higher antibacterial activity than both antibiotics tested. Oil of T. 
algeriensis showed equal antibacterial potential as streptomycin but higher than ampicillin on 
the following bacteria: S. sanguis, L. acidophilus, S. pyogenes and S. aureus. T. vulgaris oil 
also exhibited higher activity than ampicillin on S. pyogenes and S. aureus. All the oils tested 
expressed much better antifungal potential than chlorhexidine 0.05%, and only 11 isolates of 
C. albicans, among the 55 tested, possessed the same susceptibility on oils and fluconazole. 
T. serpyllum and T. algeriensis oils were more active than fluconazole against C. krusei and 
two isolates of C. glabrata. 
Overall, the essential oils of T. serpyllum, T. algeriensis and T. vulgaris showed 
significant antibacterial activity, especially against S. mutans, a recognized cariogenic 
species. The oils also efficiently inhibited the growth of Candida spp., which is crucial since 
C. tropicalis, C. krusei and C. glabrata proved to be involved in the disease course and 
together with C. albicans represent more than 80% of human cavity clinical isolates (Akpan 
and Morgan, 2002). Hence, the present results support traditional use of thyme herb against 
various infections; therefore, the bioactive properties could be easily attributed to its essential 
oil. Furthermore, the obtained results also imply that thyme oils could be also useful against 
oral pathogen infections. 
The correlation between antimicrobial  activity  of  the  EOs and  their  chemical 
composition suggests that the activity of the oils could be attributed to the presence of the 
major constituent, thymol, in all the studied EOs. As a sole component, thymol was already 
presented as a good antimicrobial agent in several studies (Penalver et al., 2005; Sokovic et 
al., 2008, 2009). On the other hand, although the lowest thymol content among the three 
thyme EOs, the oil of T. serpyllum exhibited the strongest activity, implying that, although 
the thymol is the major oil constituent, obviously it is not the only one responsible for 
achieved good antimicrobial activity;  the  involvement  of  less  abundant constituents should 
also be considered. 
In numerous studies, active natural compounds have been compared with antibacterial 
compounds currently employed in dentistry, such as chlorhexidine and triclosan, in order to 
determine their relative effectiveness (Hwang et al., 2004). Taking into account some pre-set 
criteria from the relevant literature, agents with MIC values of isolated phytochemicals below 
20 mg/mL may be considered useful for development products for application against oral 
infections. Otherwise, plant derivatives with MIC values above 100 mg/mL are unlikely to be 
useful chemotherapeutic agents, because such high concentrations are almost impossible to 
achieve in vivo and often problems of toxicity occurs (Cecchini et al., 2012). 
 
3.3. Antioxidant activity 
Numerous and diverse techniques are available to evaluate the antioxidant properties 
of compounds or complex mixtures such as essential oils; however, a single procedure cannot 
identify all possible mechanisms characterizing an antioxidant. Therefore, in the present 
study, four different assays were conducted in order to evaluate in vitro antioxidant properties 
of the EOs’ samples: scavenging activity on DPPH radicals, reducing power, inhibition of 
lipid peroxidation in a β-carotene–linoleate system, and TBARS assay. 
In the DPPH assay, the radical scavenging capacity of the tested EOs increased in a 
concentration dependent manner. The values for 50% scavenging activity (EC50) are 
presented in Table 3. T. serpyllum essential oil showed the highest radical scavenging activity 
(EC50: 0.96 µg/mL), followed by T. algeriensis (EC50: 1.64 µg/mL) and T. vulgaris (EC50: 
4.80 µg/mL) oils. For the measurements of the EOs reductive abilities, the transformation of 
Fe3+ - Fe2+ in the presence of oils was investigated. The highest reducing power was detected 
for T. serpyllum, being similar to that of T. algeriensis (0.66 µg/mL and 0.68 µg/mL, 
respectively), both more than twice higher than that of T. vulgaris oil (1.54 µg/mL). Table 3 
also shows the results of β-carotene bleaching inhibition based on the loss of the yellow color 
of β-carotene due to its reaction with radicals, which are formed by linoleic acid oxidation in 
an emulsion. Again, T. serpyllum (0.11 µg/mL) essential oil was slightly better than T. 
vulgaris (0.18 µg/mL). T algeriensis (1.56 µg/mL) showed the lowest capacity of inhibition 
in this test. The antioxidant activity of the essential oils was also assessed by TBARS 
inhibition assay and the results are presented in Table 3. In this assay, the greater 
effectiveness was shown by T. serpyllum (0.004 µg/mL), while slightly lower activity was 
detected for T. vulgaris (0.005 µg/mL), and the lowest for T. algeriensis (0.31 µg/mL).  
Strong antioxidants profile of thyme oils, especially, T. serpyllum is reported by 
several studies (Kulisic et al., 2005; Stanisavljevic et al., 2011). The difference between T. 
algeriensis and T. vulgaris in two different tests could be explained by different mechanisms 
involved in corresponding assays; therefore, each plant had different compounds with speciﬁc 
capacities to participate in those mechanisms. Antioxidant activity exhibited by the oils tested 
is an evidence of traditional uses of these plants. Antioxidants are used as food additives to 
help protect against food deterioration; in 2007, the worldwide market for industrial 
antioxidants had a total volume of around 0.88 million tons. This created revenue of 
approximately 3.7 billion US-dollars (2.4 billion Euros) (Market research). The observed 
antioxidant potential should be addressed to the phenolic oil constituents (Hazzit et al., 2009) 
and reported chemoprotective effects against oxidative stress-mediated disorders, mainly due 
to its free radical scavenging and metal chelating properties. 
 
3.4. Cytotoxic activity for human tumor cell lines and non-tumor liver primary culture 
The effects of the oils on the growth of four human tumor cells lines (NCI-H460, 
MCF7, HCT15, HeLa and HepG2), represented as the concentrations that caused 50% of cell 
growth inhibition (GI50), are summarized in Table 5. 
T. serpyllum was the most potent in all the tested cell lines, presenting GI50 values that 
ranged from 7.02 - 52.69 µg/mL. Less activity was found for T. algeriensis, which showed 
similar activity against all the cell lines in the range of 62.12 - 64.79 µg/mL. The lowest 
antitumor activity was shown by T. vulgaris oil, with GI50 values of 76.02 -180.40 µg/mL. 
The three EOs did not show any effect in the tested concentrations (up to 400 µg/mL) against 
non-tumor liver primary culture PLP2. The HCT15 cell line was the most susceptible to the 
oils. Among the tumor cell lines employed, MCF-7 was the most resistant. Ellipticine was 
used as positive control for antitumor activity evaluation assays, but should not be considered 
as a standard, and comparison with EOs results should be avoided, because it is an individual 
compound and not a mixture. 
Until now, various authors have reported antitumor activities of essential oils as well 
as their components. For instance, thyme oil appears to be the most effective against PC3, 
A549 and MCF-7 cell lines. According to Ait et al. (2010), the thyme oil containing carvacrol 
as the major oil constituent has an important in vitro cytotoxic activity against tumor cells. 
Our data demonstrated that thyme essential oils inhibited the viability of several 
tumor cell lines in a concentration-dependent manner. In some cases, this activity was 
attributed to specific components of the oil. There is evidence that thymol, a constituent of 
the essential oil, could be involved in the stimulation of active proliferation of pulp 
fibroblasts (Tsukamoto et al., 1989). Whether thymol, alone or in combination with other 
components of the oil, is responsible for the observed cytotoxicity against tumor cells still 
remains to be revealed, being an important limitation of the present study. 
At non-toxic concentrations, thyme extract was also identified as a natural 
antimutagen with the possibility of enhancement of error-free DNA repair (Vukovic et al., 
1993). GI50 values below 100 mg/mL for mixtures are considered as relevant cut off points 
for activity. On this basis, and according to published guidelines, we can conclude that all the 
essential oils are promising in developing novel cytotoxic agents.  
 
4. Conclusion 
Thymol is identified as the main oil component in the three Thymus essential oils.. 
The results of antimicrobial activity of the essential oils supported the use of the tested plant 
species in the treatment of minor wounds and disorders of the oral cavity, and as an 
antibacterial agent in oral hygiene. Furthermore, strong antioxidant and antitumor activity 
supports the traditional use for the treatment of dyspepsia and other gastrointestinal 
disturbances bronchitis and pertussis; and laryngitis and tonsillitis. In all the assays, T. 
serpyllum oil showed the strongest biological activity. In addition to Thymus oils use in food 
and cosmetics, they have a great potential for applications in anti-cancer treatments and 
deserves further exploration.  
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